IE 11 is a very old Browser and it`s not supported on this site

Board of Directors

The Board of Directors of Bellevue Group AG consists of the following persons as per December 31, 2023:




Member of Board Committee 1)

First elected

Elected until

Veit de Maddalena






Prof. Dr. Urs Schenker



ARC 2)



Katrin Wehr-Seiter






Barbara Angehrn Pavik






1) Further information on the committees is given below under «Internal organization».
2) Chair Audit & Risk Committee.
3) Chair Compensation Committee.

No member of the Board of Directors of Bellevue Group AG had any operational management responsibilities for the company or a subsidiary in 2023 or in the three preceding financial years, nor do they maintain any significant business relationships with the company or a subsidiary.


Veit de Maddalena (born 1967)

Veit de Maddalena is lic. rer. pol. (Economics) from the University of Berne and holds an MSc/Master in Finance from the London Business School. He has many years of leadership experience in the financial industry and is now exclusively active as an independent director on the boards of several family-owned companies. He was elected to the Board of Directors of Bellevue Group in 2018 and has served as its chairman since 2019. Earlier in his career Veit de Maddalena was a Global Partner and Executive Board member with Rothschild & Co Group, where he was responsible for its global private banking business. He concurrently acted as CEO of Rothschild & Co Bank AG, Switzerland. He began his professional career at Credit Suisse.


Prof. Dr. Urs Schenker (born 1957)

Urs Schenker holds a doctorate in law from the University of Zurich (Dr. iur.) and Harvard (LLM). He is a titular professor at the University of St. Gallen and an attorney at Walder Wyss in Zurich, where he specializes in corporate, finance and capital markets law. Prior to that he worked for approx. 20 years as a lawyer (14 years as a partner) for Baker & McKenzie in Zurich. Urs Schenker has been a member of the Board of Directors of Bellevue Group since 2019.


Katrin Wehr-Seiter (born 1970)

Katrin Wehr-Seiter holds a degree in engineering from the Technical University of Chemnitz/DE as well as an MBA from INSEAD Business School, Fontainebleau/FR. Katrin Wehr-Seiter is Partner and Managing Director of BIP Capital Partners and BIP Investment Partners SA, Luxembourg. Previously, she was a Principal at the international private equity firm Permira and worked as an independent advisor for medium-sized companies and as a Senior Advisor for the financial investor Bridgepoint. She started her professional career at Siemens AG. Since 2019, she has been a member of the Board of Directors of Bellevue Group.


Barbara Angehrn Pavik (born 1974)

Barbara Angehrn Pavik holds a Master's degree in economics from the University of St. Gallen. She has worked in the international healthcare industry for over 20 years in various management positions, currently as CEO of Asceneuron SA, Lausanne. Prior to that, she held management positions at Vifor Pharma Group, Stepstone Pharma, Exelixis Pharmaceuticals International, Onyx Pharmaceuticals International and Amgen International, among others. Since 2023, she has been a member of the Board of Directors of Bellevue Group.

Dr. Daniel H. Sigg was not available for re-election at the 2023 Annual General Meeting and therefore stepped down from the Board of Directors on March 21, 2023.

The other mandates of the members of the Board of Directors are shown in the Compensation Report.

Election procedures

All members of the Board are elected individually by the general meeting of shareholders. The Board of Directors constitutes itself. The members of the Board of Directors are elected to a term of one year and may be reelected. There is no restriction in the number of reelections.

Statutory rules in relation to the number of permissible activities of the Board of Directors pursuant to Art. 62 (2)(1) CO 

Pursuant to Article 30 of the Articles of Association, the members of the Board of Directors may each execute a maximum of 20 activities, of which a maximum of five in listed companies. Excluded from this are activities in legal entities controlled by the company or which control the company. Also excluded from the restrictions are activities in foundations, charitable institutions and employee pension funds; however, these are restricted to a maximum of ten such activities.

According to Art. 30 of the Articles of Association, the term «activity» within the meaning of this provision refers to membership in the highest management and administrative bodies of other companies with a commercial purpose. Several activities in legal entities which are under unitary control or under the control of the same beneficial owner are considered to be one activity.

Bellevue Group uses cookies to improve website usability and ensure the best possible user experience. Use of cookies & disclaimer